Matthew D Hanserd, MD - Medicare Internal Medicine in Athens, AL

Matthew D Hanserd, MD is a medicare enrolled "Internal Medicine" physician in Athens, Alabama. He went to University Of South Alabama College Of Medicine and graduated in 2010 and has 14 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Curana Health Of Alabama Llc, Alh Hospitalist and his current practice location is 700 W Market St, Athens, Alabama. You can reach out to his office (for appointments etc.) via phone at (256) 262-6738.

Matthew D Hanserd is licensed to practice in Alabama (license number 33722) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1942524434.

Contact Information

Matthew D Hanserd, MD
700 W Market St,
Athens, AL 35611-2457
(256) 262-6738
(256) 262-6731



Physician's Profile

Full NameMatthew D Hanserd
GenderMale
SpecialityInternal Medicine
Experience14 Years
Location700 W Market St, Athens, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Matthew D Hanserd attended and graduated from University Of South Alabama College Of Medicine in 2010
  NPI Data:
  • NPI Number: 1942524434
  • Provider Enumeration Date: 03/26/2010
  • Last Update Date: 03/17/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 0345489563
  • Enrollment ID: I20150323002283

Medical Identifiers

Medical identifiers for Matthew D Hanserd such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1942524434NPI-NPPES
1531854MedicaidTN
6011134OtherTNBCBS
7100242280MedicaidKY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 49759 (Tennessee)Secondary
208M00000XHospitalist 33722 (Alabama)Secondary
208M00000XHospitalist 49759 (Tennessee)Secondary
207R00000XInternal Medicine 33722 (Alabama)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Hospice Of Limestone CountyAthens, ALHospice
Southerncare New Beacon ScottsboroScottsboro, ALHospice
Athens Limestone HospitalAthens, ALHospital
Senior Rehab & Recovery At Limestone Health FaciliAthens, ALNursing home

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Matthew D Hanserd allows following entities to bill medicare on his behalf.
Entity NameCurana Health Of Alabama Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144450347
PECOS PAC ID: 2264681220
Enrollment ID: O20121008000018

News Archive

Altuglas International launches new acrylic resins for medical devices applications

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impactmodified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

DSM needs radical change from current ‘field guide' form

The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

Cardiac CT more effective in evaluating ER patients with chest pain

Cardiac computed tomography angiography scans (CT scans that look at the heart) can provide a virtually instant verdict on whether chest pain is from blockage of the coronary arteries.

Read more Medical News

› Verified 9 days ago

Entity NameAlh Hospitalist
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770992398
PECOS PAC ID: 7517289861
Enrollment ID: O20141124001005

News Archive

Altuglas International launches new acrylic resins for medical devices applications

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impactmodified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

DSM needs radical change from current ‘field guide' form

The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

Cardiac CT more effective in evaluating ER patients with chest pain

Cardiac computed tomography angiography scans (CT scans that look at the heart) can provide a virtually instant verdict on whether chest pain is from blockage of the coronary arteries.

Read more Medical News

› Verified 9 days ago

Entity NameLeap Medical Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346897550
PECOS PAC ID: 2961834189
Enrollment ID: O20191108002083

News Archive

Altuglas International launches new acrylic resins for medical devices applications

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impactmodified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

DSM needs radical change from current ‘field guide' form

The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

Cardiac CT more effective in evaluating ER patients with chest pain

Cardiac computed tomography angiography scans (CT scans that look at the heart) can provide a virtually instant verdict on whether chest pain is from blockage of the coronary arteries.

Read more Medical News

› Verified 9 days ago

Entity NameCh Mssp Services Al Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063111979
PECOS PAC ID: 4688039142
Enrollment ID: O20230505001134

News Archive

Altuglas International launches new acrylic resins for medical devices applications

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impactmodified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

DSM needs radical change from current ‘field guide' form

The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

Cardiac CT more effective in evaluating ER patients with chest pain

Cardiac computed tomography angiography scans (CT scans that look at the heart) can provide a virtually instant verdict on whether chest pain is from blockage of the coronary arteries.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Matthew D Hanserd is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Matthew D Hanserd, MD
501 Great Circle Rd, Suite 200,
Nashville, TN 37228-1317

Ph: (615) 222-6977
Matthew D Hanserd, MD
700 W Market St,
Athens, AL 35611-2457

Ph: (256) 262-6738

News Archive

Altuglas International launches new acrylic resins for medical devices applications

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impactmodified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

RXi Pharmaceuticals reports positive results from 2 placebo-controlled double blind studies of RXI-109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109, a proprietary sd-rxRNA compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor.

DSM needs radical change from current ‘field guide' form

The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

Cardiac CT more effective in evaluating ER patients with chest pain

Cardiac computed tomography angiography scans (CT scans that look at the heart) can provide a virtually instant verdict on whether chest pain is from blockage of the coronary arteries.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Athens, AL

Arthur Eugene Mays Jr., MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: Nuclear Plant Rd, Nuclear Training Bldng, Athens, AL 35611
Phone: 256-729-2811    Fax: 256-729-2806
Albert H Scherff Iii, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 902 W Hobbs St, Athens, AL 35611
Phone: 256-771-7575    Fax: 256-771-1454
Kunal Bhuta,
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 1005 W Market St Ste 16, Athens, AL 35611
Phone: 256-232-0801    
Dr. Shashanna Ndong, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 710 W Hobbs St, Athens, AL 35611
Phone: 256-262-6380    Fax: 256-262-6384
Dr. Pauline A Lett-anderson, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 22454 Us Highway 72 Ste 330, Athens, AL 35613
Phone: 256-262-6380    
Mrs. Crystal V. Walker, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 101 Fitness Way, Suite 2700, Athens, AL 35611
Phone: 256-233-9273    Fax: 256-216-1920
Dr. James Russell Walker, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 902 W Washington St, Athens, AL 35611
Phone: 256-233-6311    Fax: 256-233-6109

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.